Receptor for Advanced Glycation Endproducts (RAGE): A Formidable Force in the Pathogenesis of the Cardiovascular Complications of DiabetesAging

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|7|8|699-710

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.7, Iss.8, 2007-12, pp. : 699-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [ Receptor for Advanced Glycation Endproducts (RAGE): Coming Full Circle in Unraveling the Pathogenesis of Chronic Disease Guest Editor: Ann Marie Schmidt ]

By  

Current Molecular Medicine, Vol. 7, Iss. 8, 2007-12 ,pp. : 697-698

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 2, Iss. 2, 2002-06 ,pp. : 135-161

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity

By Magalhães P.  

European Review of Aging and Physical Activity, Vol. 5, Iss. 1, 2008-04 ,pp. : 17-29

Springer Publishing Company

Access to resources Recommend Favorite

Alternative Routes for the Formation of Immunochemically Distinct Advanced Glycation End-products In Vivo

By  

Current Molecular Medicine, Vol. 1, Iss. 3, 2001-07 ,pp. : 305-315

Bentham Science Publishers

Access to resources Recommend Favorite

The role of advanced glycation in the pathogenesis of diabetic retinopathy

By Stitt A.W.  

Experimental and Molecular Pathology, Vol. 75, Iss. 1, 2003-08 ,pp. : 95-108

Elsevier

Access to resources Recommend Favorite